Back to results
US 2008/0076780 A1Published application
Combination of N-(3-Methoxy-5-Methylpyrazin-2-Yl)-2-(4-[1,3,4-Oxadiazol-2-Yl]Phenyl)Pyridine-3-Sulphonamide and an Anti-Mitotic Cytotoxic Agent
AssigneeAstraZeneca AB
InventorsJohn Curwen, Andrew Hughes, Donna Johnstone, Francis Boyle, Gwen Boyle
Life of this patent
Estimating the term…
Abstract
A combination, comprising N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent.
Claims21
1-25. (canceled)
A combination, comprising N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent.
A kit comprising:
- a) Compound (I), in a first unit dosage form;
- b) an anti-mitotic cytotoxic agent;
- in a second unit dosage form;
- and
- c) container means for containing said first and second dosage forms;
- and optionally
- d) with instructions for use.
4 more elements
Dependencies are inferred from the claim text.